trisequens has been researched along with estriol in 54 studies
| Studies (trisequens) | Trials (trisequens) | Recent Studies (post-2010) (trisequens) | Studies (estriol) | Trials (estriol) | Recent Studies (post-2010) (estriol) |
|---|---|---|---|---|---|
| 56 | 35 | 1 | 6,243 | 309 | 447 |
| Protein | Taxonomy | trisequens (IC50) | estriol (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 0.0017 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 8.635 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (38.89) | 18.7374 |
| 1990's | 17 (31.48) | 18.2507 |
| 2000's | 15 (27.78) | 29.6817 |
| 2010's | 1 (1.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jensen, GF; McNair, P; Myrup, B | 1 |
| Diamant, YZ; Kleinman, Y; Livshin, Y; Reisin, A; Tadmor, OP | 1 |
| Diamant, YZ; Goldstein, R; Kleinman, Y; Tadmor, OP | 1 |
| Bŭrdarova, I; Katsarova, M; Rachev, E | 1 |
| Hart, DM; Hawthorn, RJ; Spowart, K; Walsh, D | 1 |
| Ploch, E | 1 |
| Gaasemyr, M; Høvik, P; Sandvik, L; Sundsbak, HP | 1 |
| Charles, P; Eriksen, EF; Hasling, C; Melsen, F; Mosekilde, L; Steiniche, T | 1 |
| Lehmann-Willenbrock, E; Riedel, HH | 1 |
| Christiansen, C; Jensen, J | 1 |
| Levinsohn, DG | 1 |
| Christiansen, C; Jensen, J; Nilas, L | 1 |
| Assa, S; Bacalu, B; Blum, I; Blum, M; Honig, B | 1 |
| Christiansen, C | 1 |
| Christiansen, C; Jensen, J; Rødbro, P | 1 |
| Frenkel, Y; Goldwasser, B; Menczer, J; Rabinovici, J; Serr, DM | 1 |
| Christiansen, C; Gotfredsen, A; Transbøl, I | 1 |
| Christiansen, C; Riis, BJ | 1 |
| Hellberg, D; Nilsson, S | 1 |
| Carlström, K; Furuhjelm, M; Karlgren, E | 1 |
| Arnung, K; Giese, J; Hagen, C; Hilden, T; Jespersen, CM; Nielsen, F; Nielsen, MD | 1 |
| Clark, DM; Farish, E; Fletcher, CD; Hart, DM; Kitchener, H; Leggate, J; Sharpe, GL | 1 |
| Christensen, MS; Christiansen, C; Grande, P; Transbøl, I | 1 |
| Kaiser, R | 1 |
| Fink, BJ | 1 |
| Beyth, Y; Cohen, I; Fejgin, M; Goldberger, S; Segal, J; Tepper, R; Yarkoni, S | 1 |
| Rachev, E | 1 |
| Boulieu, D; Bully, C | 1 |
| Tonstad, S | 1 |
| Ulrich, LG | 1 |
| Dydowicz, M; Hadaś, K; Halerz-Nowakowska, B; Korcz-Maciejewska, M; Meczekalski, B; Warenik-Szymankiewicz, A; Wiza, M | 1 |
| Hammar, M; Nathorst-Böös, J | 1 |
| Botta, L; Helle, SI; Holly, JM; Hughes, SC; Hüls, G; Lønning, PE; Omsjø, IH | 1 |
| Bałajewicz, M; Mazanek-Mościcka, M | 1 |
| Barlow, DH; Bragg, AJ; Campbell, MJ; Nielsen, B; Sturdee, DW; Ulrich, LG; Vessey, MP; Wells, M | 1 |
| Wendlová, J | 1 |
| Coelingh Bennink, HJ; Dören, M; Holzgreve, W; Rübig, A | 1 |
| Szántó, F | 1 |
| Cacciatore, B; Hasselblatt, R; Nieminen, MS; Paakkari, I; Tikkanen, MI; Toivonen, J; Ylikorkala, O | 1 |
| Bilgen, I; Bilgin, O; Coşan Terek, M; Memiş, A; Ozşener, S; Oztekin, K; Sendağ, F | 1 |
| Fink, T; Kuhl, H; Lang, E; Leukel, P; Rohr, UD; Wiegratz, I | 1 |
| Britov, AN; Bystrova, MM; Eliseeva, NA; Gorbunov, VM; Lebedev, AV; Slasten, OP; Smetnik, VP | 1 |
| Cravent, R; Kotsopoulos, D; Liang, YL; McGrath, BP; Teede, HJ; Zoungas, S | 1 |
| Gräser, T; Koytchev, R; Müller, A; Oettel, M | 1 |
| Carlström, K; Conner, P; Gräser, T; Skoog, L; Söderqvist, G; Tani, E; von Schoultz, B; Walter, F | 1 |
| Strandberg, TE; Tikkanen, MJ; Ylikorkala, O | 1 |
| Jirapinyo, M; Jorgensen, LN; Manonai, J; Suchartwatnachai, C; Theppisai, U | 1 |
| Boon, J; Heintz, AP; Oldenhave, A; Scholten, PC | 1 |
| Andersen, TO; Eilertsen, AL; Høibraaten, E; Os, I; Sandset, PM; Sandvik, L | 1 |
| Bacchi Modena, A; Baldini, M; Benassi, L; Dei Cas, A; Luciana Barilli, A; Manotti, C; Rinaldi, M; Sgarabotto, M | 1 |
| Auler, B; Bergemann, N; Jaggy, S; Maier-Braunleder, S; Mundt, C; Parzer, P | 1 |
| Bergemann, N; Kaiser, D; Klier, C; Maier-Braunleder, S; Mundt, C; Parzer, P | 1 |
| Carlström, K; Conner, P; Löfgren, L; Lundström, E; Naessén, S; Söderqvist, G | 1 |
2 review(s) available for trisequens and estriol
| Article | Year |
|---|---|
[The unexpected occurrence of spontaneous pregnancy during hormone replacement therapy for premature menopause].
Topics: Adult; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Menopause, Premature; Norethindrone; Pregnancy; Primary Ovarian Insufficiency | 1993 |
Accumulated knowledge of Kliogest safety aspects.
Topics: Adverse Drug Reaction Reporting Systems; Drug Combinations; Estradiol; Estriol; Female; Humans; Multicenter Studies as Topic; Norethindrone | 1996 |
34 trial(s) available for trisequens and estriol
| Article | Year |
|---|---|
Cardiovascular risk factors during estrogen-norethindrone and cholecalciferol treatment.
Topics: Aged; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholecalciferol; Cholesterol; Cholesterol, HDL; Denmark; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Norethindrone; Risk Factors; Time Factors | 1992 |
Hormonal replacement therapy in patients after cervical cancer treatment.
Topics: Chlormadinone Acetate; Clinical Trials as Topic; Dienestrol; Drug Combinations; Estradiol; Estradiol Congeners; Estriol; Female; Follow-Up Studies; Humans; Norethindrone; Radiotherapy; Uterine Cervical Neoplasms | 1987 |
Comparison of continuous and sequential oestrogen-progestogen treatment in women with climacteric symptoms.
Topics: Climacteric; Drug Administration Schedule; Drug Combinations; Endometrium; Epithelial Cells; Epithelium; Estradiol; Estriol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Middle Aged; Norethindrone; Random Allocation; Uterine Hemorrhage; Vagina | 1989 |
A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis.
Topics: Administration, Oral; Aged; Bone Density; Calcium; Drug Combinations; Estradiol; Estriol; Female; Humans; Middle Aged; Norethindrone; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic | 1989 |
[Clinical and endocrinologic studies of the treatment of ovarian insufficiency manifestations following hysterectomy with intact adnexa].
Topics: Adult; Climacteric; Clinical Trials as Topic; Drug Combinations; Estradiol; Estriol; Estrogens, Conjugated (USP); Female; Humans; Hysterectomy; Menopause, Premature; Norethindrone; Plant Extracts; Random Allocation | 1988 |
Dose-response effects on serum lipids and lipoproteins following combined oestrogen-progestogen therapy in post-menopausal women.
Topics: Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estriol; Female; Humans; Lipids; Lipoproteins; Menopause; Middle Aged; Norethindrone | 1987 |
Photon absorptiometry studies in osteoporosis.
Topics: Bone and Bones; Calcitriol; Calcium; Clinical Trials as Topic; Drug Combinations; Estradiol; Estriol; Female; Fluorides; Humans; Hydroxycholecalciferols; Menopause; Middle Aged; Minerals; Norethindrone; Osteoporosis; Radionuclide Imaging; Vitamin D | 1985 |
Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause.
Topics: Adult; Bone Resorption; Drug Combinations; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Menopause; Middle Aged; Norethindrone; Osteoporosis; Smoking | 1985 |
Effect of natural oestrogen/gestagen therapy on uric acid metabolism in post-menopausal women.
Topics: Adult; Bendroflumethiazide; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Female; Humans; Menopause; Middle Aged; Norethindrone; Uric Acid | 1983 |
Does calcium potentiate the bone-preserving effect of oestrogen treatment in early post-menopausal women by a change in vitamin D metabolism?
Topics: Calcium; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Estradiol; Estriol; Female; Humans; Hydroxycholecalciferols; Menopause; Middle Aged; Norethindrone; Osteoporosis | 1984 |
The effect of estrogen therapy on somatic and psychical symptoms in postmenopausal women.
Topics: Aged; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Mental Disorders; Middle Aged; Norethindrone | 1984 |
Low-risk lipoprotein pattern in post-menopausal women on sequential oestrogen/progestogen treatment.
Topics: Adult; Cholesterol; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estriol; Female; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Menopause; Middle Aged; Norethindrone; Placebos | 1984 |
[Kliogest--the possibility of hormonal substitution in the postmenopause].
Topics: Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Time Factors | 1993 |
Combined hormone replacement therapy with oestradiol and norethisterone acetate: effects in hyperlipidaemia.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Hyperlipidemias; Middle Aged; Norethindrone | 1996 |
[Effect of Kliogest therapy on serum blood lipids in postmenopausal women].
Topics: Cholesterol; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Humans; Lipids; Luteinizing Hormone; Middle Aged; Norethindrone; Postmenopause; Reference Values; Triglycerides | 1995 |
Effect on sexual life--a comparison between tibolone and a continuous estradiol-norethisterone acetate regimen.
Topics: Anabolic Agents; Climacteric; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Libido; Middle Aged; Norethindrone; Norpregnenes; Sexual Behavior | 1997 |
Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Cross-Over Studies; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Middle Aged; Norethindrone; Postmenopause; Somatomedins | 1996 |
[Evaluation of hormone therapy in women during postmenopause with the help of Kliogest].
Topics: Adult; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Middle Aged; Norethindrone; Postmenopause | 1996 |
Quality of life and patient preference for sequential versus continuous combined HRT: the UK Kliofem multicenter study experience. UK Continuous Combined HRT Study Investigators.
Topics: Aged; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Middle Aged; Norethindrone; Patient Compliance; Postmenopause; Quality of Life; United Kingdom | 1997 |
Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy.
Topics: Aged; Anabolic Agents; Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endosonography; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Incidence; Middle Aged; Norethindrone; Norpregnenes; Prospective Studies; Tablets; Uterine Hemorrhage; Vagina | 1999 |
[Combination of hormone replacement therapy with buspirone in the treatment of climacteric complaints].
Topics: Anti-Anxiety Agents; Buspirone; Climacteric; Drug Combinations; Drug Therapy, Combination; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Treatment Outcome | 2000 |
Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Prospective Studies; Statistics, Nonparametric | 2001 |
[Cross-over comparison of the pharmacokinetics of estradiol during hormone replacement therapy with estradiol valerate or micronized estradiol].
Topics: Aged; Contraceptives, Oral, Sequential; Cross-Over Studies; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Immunoassay; Luminescent Measurements; Middle Aged; Norethindrone; Postmenopause | 2001 |
[Hormone replacement therapy in women with arterial hypertension in peri- and postmenopause: hemodynamic effects].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Betaxolol; Climacteric; Drug Combinations; Drug Therapy, Combination; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Hemodynamics; Humans; Hypertension; Middle Aged; Norethindrone; Postmenopause | 2001 |
A placebo-controlled trial of long-term oral combined continuous hormone replacement therapy in postmenopausal women: effects on arterial compliance and endothelial function.
Topics: Analysis of Variance; Double-Blind Method; Drug Combinations; Endothelium, Vascular; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Lipoprotein(a); Middle Aged; Norethindrone; Postmenopause; Vascular Resistance; Vasodilation | 2001 |
Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest for continuous combined hormone replacement therapy in postmenopausal women.
Topics: Biopsy; Breast Diseases; Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endometrium; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Nandrolone; Norethindrone; Postmenopause; Prospective Studies; Therapeutic Equivalency; Treatment Outcome; Uterine Hemorrhage | 2000 |
Breast cell proliferation in postmenopausal women during HRT evaluated through fine needle aspiration cytology.
Topics: Biopsy, Needle; Breast; Cell Division; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Estrone; Female; Humans; Ki-67 Antigen; Middle Aged; Nandrolone; Norethindrone; Postmenopause; Prospective Studies | 2003 |
Differing effects of oral and transdermal hormone replacement therapy on cardiovascular risk factors in healthy postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Age Factors; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Hypoglycemic Agents; Insulin; Lipids; Middle Aged; Norethindrone; Reference Values; Risk Factors | 2003 |
Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
Topics: Administration, Oral; Aged; Bone Density; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Middle Aged; Norethindrone; Osteoporosis, Postmenopausal; Progestins; Thailand; Treatment Outcome; Uterine Hemorrhage | 2003 |
Continuous intrauterine compared with cyclic oral progestin administration in perimenopausal HRT.
Topics: Administration, Oral; Climacteric; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Norethindrone; Patient Compliance | 2003 |
The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis.
Topics: Administration, Cutaneous; Administration, Oral; Blood Coagulation; C-Reactive Protein; Drug Combinations; Estradiol; Estriol; Female; Hormone Replacement Therapy; Humans; Interleukin-6; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; P-Selectin; Risk Factors; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; Venous Thrombosis | 2005 |
Effects of raloxifene and continuous combined hormone therapy on haemostasis variables: a multicenter, randomized, double-blind study.
Topics: Aged; Body Mass Index; Contraceptives, Oral, Synthetic; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Female; Hemostasis; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Time Factors | 2007 |
Estrogen and comprehension of metaphoric speech in women suffering from schizophrenia: results of a double-blind, placebo-controlled trial.
Topics: Adult; Antipsychotic Agents; Attention; Brief Psychiatric Rating Scale; Comprehension; Cross-Over Studies; Decision Making; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Metaphor; Middle Aged; Neuropsychological Tests; Norethindrone; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Speech Perception; Thinking; Verbal Behavior | 2008 |
Testosterone and gonadotropins but not estrogen associated with spatial ability in women suffering from schizophrenia: a double-blind, placebo-controlled study.
Topics: Adult; Antipsychotic Agents; Cross-Over Studies; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstrual Cycle; Norethindrone; Schizophrenia; Schizophrenic Psychology; Space Perception; Spatial Behavior; Testosterone | 2008 |
18 other study(ies) available for trisequens and estriol
| Article | Year |
|---|---|
The effects of two fixed hormonal replacement therapy protocols on blood lipid profile.
Topics: Clinical Protocols; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipids; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Prospective Studies | 1992 |
The effect of desogestrel for hormone replacement therapy on the blood lipid profiles of postmenopausal women.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Desogestrel; Drug Combinations; Drug Therapy, Combination; Estradiol; Estradiol Congeners; Estriol; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norethindrone; Prospective Studies; Time Factors; Triglycerides | 1992 |
[The treatment and prevention of premenopausal uterine hemorrhages with Trisequens].
Topics: Climacteric; Drug Combinations; Drug Evaluation; Estradiol; Estriol; Female; Humans; Menopause; Menstruation; Middle Aged; Norethindrone; Uterine Hemorrhage | 1991 |
The endometrial status of women on long-term continuous combined hormone replacement therapy.
Topics: Animals; Drug Combinations; Endometrium; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Hysteroscopy; Immunoenzyme Techniques; Mice; Norethindrone; Rats; Receptors, Estrogen; Receptors, Progesterone; Time Factors | 1991 |
Confusion between oral contraceptives and oestrogen replacement preparations.
Topics: Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Drug Combinations; Drug Packaging; Estradiol; Estriol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Medication Errors; Norethindrone; Norgestrel | 1988 |
Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapy.
Topics: Cholesterol; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Estradiol; Estriol; Estrogens; Female; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate | 1986 |
The influence of short-term estrogen replacement therapy (ERT) on the blood pressure and daily urinary catecholamine excretion in a small group of post-menopausal women.
Topics: Blood Pressure; Catecholamines; Drug Combinations; Estradiol; Estriol; Female; Humans; Menopause; Middle Aged; Norethindrone | 1986 |
Acute abdominal condition caused by retrograde bleeding in a postmenopausal patient on estrogen-progestogen therapy.
Topics: Abdomen, Acute; Aged; Climacteric; Drug Combinations; Estradiol; Estriol; Female; Humans; Menopause; Norethindrone; Uterine Hemorrhage | 1985 |
Comparison of a triphasic oestradiol/norethisterone acetate preparation with and without an oestriol component in the treatment of climacteric complaints.
Topics: Adult; Climacteric; Double-Blind Method; Drug Combinations; Drug Evaluation; Endometrium; Estradiol; Estriol; Female; Follicle Stimulating Hormone; Humans; Liver; Liver Function Tests; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Random Allocation | 1984 |
Effects of natural oestrogen therapy on blood pressure and renin-angiotensin system in normotensive and hypertensive menopausal women.
Topics: Adult; Angiotensinogen; Blood Pressure; Climacteric; Drug Combinations; Estradiol; Estriol; Estrogens; Follicle Stimulating Hormone; Humans; Hypertension; Male; Middle Aged; Norethindrone; Renin-Angiotensin System | 1983 |
Effect on lipoproteins of Trisequens, a combined hormone preparation.
Topics: Adult; Castration; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Coronary Disease; Drug Combinations; Estradiol; Estriol; Female; Humans; Lipoproteins; Lipoproteins, VLDL; Menopause; Middle Aged; Norethindrone; Risk; Triglycerides | 1984 |
Duration of the climacteric syndrome in women treated by hormonal substitution and in controls.
Topics: Administration, Oral; Androstenols; Climacteric; Drug Combinations; Estradiol; Estriol; Estrogens; Female; Heptanoates; Humans; Infusions, Parenteral; Middle Aged; Norethindrone; Progesterone; Time Factors | 1984 |
Endometrial changes after long-term use of continuous oestrogen and cyclic progestogen.
Topics: Adult; Biopsy; Climacteric; Drug Combinations; Endometrium; Estradiol; Estriol; Female; Humans; Hyperplasia; Middle Aged; Norethindrone; Time Factors; Turner Syndrome | 1984 |
Trisequens.
Topics: Drug Combinations; Estradiol; Estriol; Female; Humans; Menopause; Norethindrone | 1981 |
Estrogen replacement in postmenopausal women: are we currently overdosing our patients?
Topics: Adult; Body Mass Index; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone | 1994 |
[Effect of Kliogest on bone metabolism, bone mineral density and quality of life in postmenopausal patients].
Topics: Bone and Bones; Bone Density; Climacteric; Collagen; Collagen Type I; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Osteocalcin; Peptides; Quality of Life | 1998 |
Mammographic density changes during different postmenopausal hormone replacement therapies.
Topics: Cyproterone Acetate; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Progesterone Congeners; Retrospective Studies; Time Factors | 2001 |
Estrone - a partial estradiol antagonist in the normal breast.
Topics: Aged; Breast; Breast Density; Breast Neoplasms; Contraceptives, Oral; Drug Combinations; Estradiol; Estriol; Estrogen Antagonists; Estrogen Replacement Therapy; Estrone; Female; Humans; Mammary Glands, Human; Mammography; Middle Aged; Norethindrone | 2015 |